Digestive and Liver Disease

Article	Citations
Beyond inflammation: Expanding the horizon on vascular risk assessment in inflammatory	80
Comment on ``Clinical characteristics of immune checkpoint inhibitor-related pancreatic injury with pancreatitis in patients with advanced malignancies''	75
Relationship between recipient/donor features and liver stiffness measurement in the first year after liver transplantation	72
Mapping the hepatic mtDNA genomic landscape in patients with MASLD: The Era of GPT-4 Artificial Intelligence	71
Identification of causes and patterns of albumin structural damages in commercial formulations	63
Assessment of sarcopenia with ultrasound-based measurements in patients with liver cirrhosis and correlation with clinical outcomes	59
Cardiometabolic risk factors and clinical course of liver cirrhosis	55
Full Title Page /Editorial Board	54
Comment on ``Dietary lipophilic index and odds of metabolic dysfunction-associated steatotic liver disease (MASLD): A population-based survey''	52
Association between remnant cholesterol and metabolic dysfunction-associated steatotic liver disease in the elderly	51
Letter to the editor: Comment on “Synergistic effect of oral exclusive enteral nutrition and biologic in induction therapy for adult Crohn disease”	50
Renal cell carcinoma metastasis as an atypical cause of gastrointestinal bleeding	49
OC.04.7 EFFECT OF MTOR INHIBITION ON EXOSOMES ISOLATED FROMPC CELLS WITH DIFFERENT KRAS MUTATIONS	45
OC.09.5 ADVANCING IN ERCP: THE SLIM DUODENOSCOPE AS A CORNERSTONE FOR CHALLENGING ANATOMIES – INSIGHTS FROM AN ITALIAN CASE SERIES	43
OC.22.3 THREE-YEAR OUTCOMES OF ENDOSCOPIC SLEEVE GASTROPLASTY BY OBESITY CLASS	41
OC.09.9 BALANCING RISKS AND BENEFITS: EVALUATING THE SAFETYAND EFFICACY OF CHOLANGIOPANCREATOSCOPY IN ELDERLY AND FRAIL POPULATIONS	41
T.08.4 PRELIMINARY DATA FROM AN ONGOING MULTICENTER STUDY: EVALUATION OF THE DIAGNOSTIC ACCURACY OF CHATGPT-4 IN THE RECOGNITION AND CLASSIFICATION OF ESOPHAGEAL VARICES	41
OC.17.5 ENDOSCOPIC VACUUM THERAPY (EVT) FOR THE MANAGEMENT OF UPPER GASTROINTESTINAL TRACT LEAKS AND DEFECTS: A RETROSPECTIVE STUDY FROM ATERTIARY REFERRAL CENTER IN NEARLY 100 PATIENTS	41
T.10.4 APULIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (AN-IBD) SAFETY PROFILE: PILOT DATA	40
T.03.5 EVALUATION OF RECTALWALL THICKNESS MEASUREMENT SENSITIVITY VIA TRANSABDOMINAL ULTRASOUND TO ASSESS MUCOSAL ACTIVITY IN ULCERATIVE COLITIS: COULD THIS BE A USEFUL NON-INVASIVE TOOL? A PRELIMINAR	40
Ileocaecal Crohn's disease. To resect or not to resect, is that the question?	39
Other than Insulin Antidiabetic Treatment Associates with Better Status of Frailty in Patients with Cirrhosis and Type 2 Diabetes on Waiting List for Liver Transplantation	38
OC.06.4 DEMOGRAPHIC DIFFERENCES IN LEFT-TO-RIGHT SHIFT OF COLON CANCER OVER 25 YEARS: RESULTS FROM ROBUST ANALYSIS OF CANCER REGISTRY DATA	37
Liver transplantation following HCC rupture and long-term immunotherapy: a case report	37
Gaining knowledge for the choice and use of systemic therapies in the treatment of hepatocellular carcinoma also requires real life and investigators conducted observational studies	36

OC.04.1 SURGERY IN HIGH-RISK PAEDIATRIC CROHN'S DISEASE TREATED WITH UP-FRONT ANTI-TNF AGENTS AND LONG-STANDING BIOLOGIC THERAPY	36
Impact of ISO score on oncological outcomes and survival in liver transplant candidates with hepatocellular carcinoma	35
T.04.5: COMPARISON OF SUBCUTANEOUS AND INTRAVENOUS INFLIXIMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE SHOWED NO DIFFERENCES IN IMMUNOGENICITY OR TREATMENT PERSISTENCE AT ONE YEAR	35
Impact of laparoscopic liver resection for access to the waiting list of a single regional liver transplant center in southern Italy: entry and dropout flows’ analysis	35
Fully automated approach of machine learning combined with deep learning: How to predict the onset of major cardiovascular events in NAFLD patients	35
T.12.2: THE LEVELS OF AFP, PIVKA-II AND GPC-3 SERUM BIOMARKERS AT DIAGNOSIS CORRELATE WITH HCC CLINICAL-PATHOLOGICAL FEATURES AND WITH OVERALL SURVIVAL	35
Characteristics and management of hepatocellular carcinoma (HCC) in Sicily: first results of the HCC Sicily Multidisciplinary Network	34
Application of Machine Learning Model-3P to Predict Portal Hypertension in Patient with Hepatocellular Carcinoma	34
Transarterial Radioembolization for Unresectable Hepatocellular Carcinoma: A single-center experience	33
T.04.4: CLINICAL OUTCOME AFTER CROHN'S DISEASE-RELATED SURGERY DIFFERENT FROM ILEO-COLONIC RESECTION	33
Recurrent IgG4 cholangitis after liver transplantation: Back to the future	32
T.01.6 THE EFFICACY OF SIX-FOOD ELIMINATION DIET IS LOWER DURING POLLEN SEASON IN ADULT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS SENSITIZED TO POLLENS	32
T.10.4 INTESTINAL ULTRASONOGRAPHY PROFILING OF PATIENTS WITH CROHN'S DISEASE PREDICTS LONG TERM CLINICAL REMISSION	31
V.01.7 COMPLETE INTRA-PERITONEAL MALDEPLOYMENT OF A LAMS DURING EUS-GEA FOR MGOO: RESCUE RETRIEVAL WITH PERITONEOSCOPY THROUGH NOTES	30
OC.03.4 PREVALENCE OF AUTOIMMUNE ATROPHIC GASTRITIS IN A GASTROENTEROLOGICAL SETTING BY USING AN EXTENSIVE SCREENING STRATEGY VS A CASE FINDING STRATEGY	30
The role of ustekinumab and vedolizumab in management of extra intestinal manifestations in inflammatory bowel disease	30
An unusual lesion of the gallbladder mimicking gallbladder carcinoma	29
OC.12.5 MYOSTEATOSIS IS NOT ASSOCIATED WITH COMPLICATIONS OR SURVIVAL IN HCC PATIENTS UNDERGOING TRANS ARTERIAL EMBOLIZATION	29
T.11.7 THE PROGNOSTIC ROLE OF RADIOMICS IN GASTRO-ENTEROPANCREATIC NEUROENDOCRINE TUMORS	29
BOC.04.1: ANALYSIS OF IMMUNOLOGICALVARIABLES IN EX VIVO TOFACITINIB-TREATED HUMAN BIOPSIES FROM ACTIVE ULCERATIVE COLITIS PATIENTS TO PREDICT CLINICAL RESPONSE (THE AVATAR STUDY)	29
Author's Reply: “NRF2 in cancer: An insufficiently explored and controversial research area”	28
OC.01.3: EVENING CHRONOTYPE CORRELATES WITH SEVERITY OF FUNCTIONAL DYSPEPSIA AND AFFECT SLEEP QUALITY	28
Fatty Acid Synthase expression promotes the malignant features of cholangiocarcinoma cells and predicts shorter survival in patients	27
T.05.10 CLINICAL HETEROGENEITY OF ADULT COELIAC DISEASE ACCORDING TO THE AGE AT ONSET: AN ITALIAN MULTICENTRIC STUDY	27
V.04.5: OVER THE SCOPE CLIPS: A RESCUE THERAPY FOR DUODENAL PERFORATION DUE TO BILIARY STENT MIGRATION	26
Liposomal doxorubicin targeted with the Fab' of atezolizumab as a novel strategy against HCC	26
Changes in mean arterial pressure are inadequate to guide treatment with terlipressin and albumin in patients with hepatorenal syndrome - acute kidney injury	26
Venous hepatic aneurysms	26
A two-sample Mendelian randomization study to identity microbiome signatures in patients with Non-alcoholic fatty liver disease	26
ABCA8: A potential therapeutic target in the treatment of colorectal cancer?	25
OC.08.4: ARTIFICIAL INTELLIGENCE TOOLS PREDICT EOSINOPHILIC ESOPHAGITIS IN ADULTS REPORTING DYSPHAGIA: DEVELOPMENT, EXTERNALVALIDATION, AND SOFTWARE CREATION FOR POINT-OF-CARE USE	25
ACNMD26-387: ALBUMIN AS A PREDICTOR OF LONG-TERM POST-TIPS SURVIVAL	25
Does HLA-G play a role in PBC?	25
Do glucagon-like peptide-1 based therapies alter the risk of late-onset inflammatory bowel disease?	25
Triplet chemotherapy with or without bevacizumab as first line treatment for metastatic colorectal cancer: An AGEO multicenter real-world study	25
Multiple small intestinal ulcers with SLCO2A1 mutation in a Chinese patient	25
Comment on “Effect of vessels that encapsulate tumor clusters (VETC) and different stages of hepatocellular carcinoma after hepatectomy”	25
Clinical prediction models in minimal hepatic encephalopathy: how far can they go?	25
ACNMD26-293: ENDOSCOPIC ULTRASOUND SHEAR-WAVE ELASTOGRAPHY FOR DIAGNOSIS OF CHRONIC PANCREATITIS IN AWESTERN POPULATION: PRELIMINARY RESULTS FROM THE SWEG STUDY	24
ACNMD26-82: PREMEDICATION FOR IMPROVING VISIBILITY DURING ESOPHAGOGASTRODUODENOSCOPY: A SINGLE CENTER RANDOMIZED CONTROLLED TRIAL	24
ACNMD26-463: ENDOSCOPIC ULTRASOUND WITH DETECTIVE FLOW IMAGING (DFI) FOR PREDICTING PANCREATIC NEUROENDOCRINE TUMOUR GRADE: SINGLE CENTRE EXPERIENCE	24
ACNMD26-295: REDEFINING SURGICAL RISK IN CROHN’S DISEASE: THE PERSISTENT ROLE OF NOD2 GENOTYPE IN THE BIOLOGIC ERA	24
ACNMD26-630: ENDOSCOPIC ULTRASOUND-GUIDED GASTROENTEROSTOMY TO TREAT PATIENTS WITH BENIGNGASTRIC OUTLET OBSTRUCTION: A MULTICENTER SERIES	23
ACNMD26-346: DO WE REALLY NEED TWO DIFFERENT ESOPHAGEAL DGBI?	23
ACNMD26-163: DUPILUMAB IS EFFICACIOUS REGARDLESS OF ENDOSCOPIC PHENOTYPE: POST HOC ANALYSIS OF THE LIBERTY EOE TREET STUDY	23
ACNMD26-613: POSTOPERATIVE HIGH-RESOLUTION MANOMETRY IN CLINICAL PRACTICE: VALIDATION OF THE PADOVA CLASSIFICATION	23
Accuracy of automated 3D biliary tract reconstruction compared to ERCP to assess Bismuth-Corlette classification in patients with perihilar cholangiocarcinoma	23
Deep learning for histopathological diagnosis of esophageal squamous cell carcinoma in biopsies: A multicenter analysis	22
Reconsidering the clinical implications of oral butyrate supplementation in inflammatory bowel disease	22
Cannulation rates and technical performance evaluation of commericially available single-use duodenoscopes for endoscopic retrograde cholangiopancreatography: A systematic review and meta-analysis	22

Exploring novel biomarkers in pediatric ulcerative colitis: The role of Lipocalin-2, MMP-9, and MMP-9/LCN-2 complex	22
Safety of same day discharge after Zenker's diverticulum peroral endoscopic myotomy	22
Outcomes and predictors of delayed endoscopic biliary drainage for severe acute cholangitis due to choledocholithiasis in an intensive care unit	22
Exploring occupational toxicant exposures in patients with metabolic dysfunction-associated steatotic liver disease: A prospective pilot study	21
Predictive factors of health related quality of life in children and adolescents with celiac disease: An Italian multicenter study on behalf of the SIGENP	21
NOSTRIN is an emerging positive regulator of decompensated cirrhotic patients with portal hypertension	21
AISF practice guidance on the treatment of primary biliary cholangitis: A 2026 update	20
Immunotherapy in MSI/dMMR tumors in the perioperative setting: The IMHOTEP trial	20
Differences in clinical manifestations and the fecal microbiome between irritable bowel syndrome and small intestinal bacterial overgrowth	20
Mesenteric panniculitis is associated with cardiovascular risk-factors: A case-control study	20
Autoimmune atrophic gastritis and coeliac disease: A case-control study	20
Multi-focal dysplasia is associated with high recurrence rates after successful ablation of dysplastic Barrett's esophagus	20
Establishing a nomogram for predicting necrotizing enterocolitis in premature infants: A retrospective multicenter cohort study	19
Glucagon-like peptide-1 receptor agonists increase the risk of residual gastric content and pulmonary aspiration on upper endoscopy: A meta-analysis	19
More advanced presentation but similar survival for hepatocellular carcinoma in HIV positive compared to HIV-negative patients: a retrospective cohort analysis	19
Assessment of sarcopenia improves the prediction of post-TIPS mortality in older adult patients with cirrhosis	19
Digital single-operator cholangioscopy in diagnostic and therapeutic bilio-pancreatic diseases: A prospective, multicenter study	19
Persistence, effectiveness and safety of ustekinumab and vedolizumab therapy for complex perianal fistula in Crohn's disease: The HEAL study from GETECCU	19
Diagnostic yield of whole exome sequencing in adult-onset cholestatic liver disease	19
How macronutrients and pancreatic enzyme supplements dose variability affect fat, protein and starch absorption in children with cystic fibrosis	19
Advancing endoscopic papillectomy: Outcomes and insights from a single-center learning experience	19
Portal Vein Recanalization-Transjugular Intrahepatic Portosystemic Shunt (PVR-TIPS) in patients with anatomical portal contraindication to liver transplantation: feasibility and clinical implication	18
OC.17.3 PERORAL ENDOSCOPIC MYOTOMY FOR SPASTIC ESOPHAGEAL MOTILITY DISORDERS: A SINGLE-CENTER RETROSPECTIVE ANALYSIS	18
OC.05.5 HUMAN EXTRACHROMOSOMAL CIRCULAR DNA (ECCDNA) IS A NOVEL BIOMARKER IN INFLAMMATORY BOWEL DISEASE	18
T.10.7 WELCOME TO THE APULIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (AN-IBD): A PROSPECTIVE OBSERVATIONAL REGIONAL DATABASE ON THE SAFETY AND EFFECTIVENESS OF ALL LICENSED THERAPIES. WHAT IS THE ENRO	18
OC.20.5 REAL-TIME ELASTOGRAPHY AS A PREDICTOR OF INTESTINAL WALL FIBROSIS IN CROHN’S DISEASE	18
OC.10.1 MASLD AND FIB4 ARE INDEPENDENT PREDICTORS OF MAJOR ADVERSE LIVER OUTCOMES AND CARDIOVASCULAR EVENTS IN TYPE 2 DIABETES: FINDINGS FROM A SINGLE-CENTER COHORT USING AI-DRIVEN MACHINE LEARNING	18
OC.22.4 “REALWORLD” PERCUTANEOUS ENDOSCOPIC GASTROSTOMY MANAGEMENT IN ENDOSCOPY CENTRES	18
Direct portal pressure gradient measurement in patients with porto-sinusoidal vascular disease	18
OC.22.1 PREVALENCE OF SARCOPENIA IN A COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE: OBSERVATIONAL STUDY IN A TERTIARY CARE CENTRE	18
BOC.01.2 TRANSORAL SEPTOTOMY VERSUS Z-POEM IN THE TREATMENT OF ZENKER DIVERTICULUM: A MULTICENTER CASE-MATCHED COMPARATIVE STUDY	18
OC.14.3 THE ANTHELMINTIC DRUG RAFOXANIDE PROMOTES OXIDATIVE STRESS AND VDAC1 OPENING LEADING TO MITOCHONDRIAL DYSFUNCTION IN COLORECTAL CANCER CELLS	18
OC.05.1 ROLE OF RADIOMICS IN PREDICTING THE DEGREE OF INTESTINAL FIBROSIS IN PATIENTS WITH CROHN’S DISEASE	18
ACNMD26-543: SYMPTOM BURDEN AND QUALITY OF LIFE IN ROME IV POSITIVE UNINVESTIGATED DYSPEPSIA: INSIGHTS FROM THE GUESS MULTICENTRE STUDY	17
Environmental enteropathy and inflammatory bowel disease are not mutually exclusive	17
Full Title Page /Editorial Board	17
ACNMD26-13: BASELINE ANTI-αVβ6 PREDICTS 12-MONTH REMISSION IN ULCERATIVE COLITIS	17
ACNMD26-292: TEXTBOOK OUTCOMES OF EUS-GUIDED HEPATICOGASTROSTOMY ACCORDING TO INDICATION AND PRESENTING ANATOMY: A PROSPECTIVE COHORT STUDY	17
V.02.7 THROUGH THE LAMS INTERVENTION AFTER ENDOSCOPIC ULTRASOUND-GUIDED RESIDUAL GALLBLADDER DRAINAGE AS RESCUE TREATMENT IN NON SURGICAL CANDIDATE WITH RECURRENT BILIARY ABDOMINAL PAIN	17
Pancreatic steatosis and post-operative pancreatic fistula after pancreatectomy	17
VEPH1 suppresses the progression of gastric cancer by regulating the Hippo-YAP signalling pathway	17
ACNMD26-338: LONG-TERM COHORTANALYSIS OF HBV BASIC CORE PROMOTER, PRE-CORE, AND CORE REGION HETEROGENEITY	17
ACNMD26-537: DIAGNOSTIC ACCURACY AND SAFETY OF A NEWLY DESIGNED FRANSEEN-TIP NEEDLE WITH MACROSCOPIC ON-SITE EVALUATION FOR SOLID LESIONS: A MULTICENTER STUDY	17
Delineating unique MASH-endothelial cells in metabolic dysfunction-associated steatotic liver disease using single-cell lensing	17
Author's Reply: Comment on “A systematic review and meta-analysis: the role of potassium-competitive acid blockers in endoscopy-negative reflux disease”	17
ACNMD26-305: FLIP PANOMETRY FREQUENTLY IDENTIFIES ABNORMALITIES IN PATIENTS WITH DYSPHAGIA AND NORMAL OR INCONCLUSIVE MANOMETRY GUIDING CLINICAL MANAGEMENT	17
IgA-autoantibodies to Histone 2B and alcohol-associated liver disease (ALD): Another drop in the ocean of potential useful biomarkers	16
T.12.7 IS ONE PASS ENOUGH FOR THE DIAGNOSIS OF THE PANCREATIC MASSES DURING EUS-FNB? A PROSPECTIVE STUDY	16
T.07.1 NATURAL HISTORY AND CLINICAL IMPACT OF NON-NEOPLASTIC PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS WITH HEPATOCELLULAR CARCINOMA	16
Is it time to introduce health coaching in inflammatory bowel disease management?	16
OC.03.1 THE SAME FACTORS IMPACT DIFFERENTLY ON TIME TO DEATH IN PATIENTS WITH ACUTE NON-VARICEAL UPPER GASTROINTESTINAL BLEEDING: A PROSPECTIVE COHORT STUDY	16
Author's reply: “Comment on “The association analysis between exposure to volatile organic compounds and fatty liver disease in US Adults””	16
T.01.10 ITALIAN SOCIETY FOR DIGESTIVE ENDOSCOPY (SIED), ITALIAN ASSOCIATION OF HEALTHCARE TECHNICAL OPERATORS (ANOTE) AND ACCREDITATION ASSESSMENT: EVALUATION OF MANAGEMENT AND ORGANIZATIONAL EFFICACY	16
T.04.3 USING A NEW ELECTROCAUTERY LUMEN APPOSING METAL STENT TO PERFORM AN EUS-GUIDED GASTROENTEROSTOMY IN TREATMENT OF GASTRIC OUTLET OBSTRUCTION	16
The expression of Aurora Kinase A and its potential role as a regulator of Programmed Death-Ligand 1 in hepatocellular carcinoma: Implications for immunotherapy and immune checkpoint regulation in hep	15
OC.01.1 EUS-GUIDED GASTROENTEROSTOMY FOR MANAGEMENT OF MALIGNANT GASTRIC OUTLET OBSTRUCTION: A PROSPECTIVE SERIES FROM THE PROTECT REGISTRY	15
Hepatocellular Carcinoma in HIV-Infected Patients: Clinical Presentation and Outcomes	15
Long-term treatment with fibrates and ursodeoxycholic acid in people with Primary Sclerosing Cholangitis is safe and associated with persistent clinical and biochemical improvement	15
T.04.6: ERECTILE AND PROSTATIC DYSFUNCTION IN PATIENTS WITH CHRONIC INFLAMMATORY BOWEL DISEASE	15
OC.11.3 THERAPEUTIC EFFECTS OF MELATONIN IN COMBINATION WITH LACTOBACILLUS RHAMNOSUS GG IN PEDIATRIC FUNCTIONAL ABDOMINAL PAIN DISORDERS: A PILOT CLINICAL STUDY	15
Safety and immunogenicity of booster dose in patients with chronic liver disease	15
OC.05.5 ENDOSCOPIC TISSUE ACQUISITION DURING ERCP IN BILIARY STENOSIS: RETROSPECTIVE ANALYSIS OF CASES FROM A TERTIARY REFERRAL HOSPITAL	15
SIRT5 rs12216101 T>G variant is associated with oxidative stress and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease	15
PC.01.3 LONG-TERM OUTCOME OF VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE ASSOCIATED WITH PRIMARY SCLEROSING CHOLANGITIS: A MULTICENTER STUDY FROM THE PEDIATRIC IBD PORTO GROUP OF ESPGHAN	15
Clinical utility of a targeted panel sequencing for the diagnosis of chronic hereditary liver diseases in adult patients	15
T.05.2 DO WE NEED THREE DIFFERENT TYPES OF ESOPHAGOGASTRIC JUNCTION?	15
T.12.6 ALARMING CORRELATION BETWEEN MULTIDRUG-RESISTANT BACTERIOBILIA AND MORBIDITY AFTER PANCREATIC SURGERY	15
T.04.8 A MULTICENTRIC SURVEY ON THE AVAILABILITY AND USE OF ANESTHESIOLOGIST-DIRECTED CARE IN GASTROINTESTINAL ENDOSCOPY	15
OC.12.1 QUANTITATIVE HBV/HDV MARKERS HELP TO DISTINGUISH DIFFERENT CLINIC/VIROLOGIC PHASES OF CHRONIC HEPATITIS DELTA	15
Role of rare and common variants in the diagnosis of adults with cryptogenic liver and lipid disorders	15
Prevalence and Characterization of Resistance Profiles of “Unusual” HCV Subtypes in Italy within the Italian Resistance Network Vironet C	14
T.03.4: ENDOSCOPIC EVALUATION OF NEWLY REPORTED INTESTINAL WALL THICKENING: PRELIMINARY RESULTS	14
OC.07.6: THE BURDEN OF PSYCHIATRIC MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASES: A SYSTEMATIC REVIEW WITH META-ANALYSIS	14
OC.01.7: AN EMILIN1-ALTERED MICROENVIRONMENT PROMOTES TUMORCELL PROLIFERATIONAND LYMPHATIC DYSFUNCTION IN GASTRIC CANCER	14
Utility of novel composite index in predicting the prognosis of total neoadjuvant therapy for locally advanced rectal cancer: A multicenter real-world cohort study	14
Tofacitinib in ulcerative colitis – In the era of precision medicine’	14
BOC.01.7: EFFICACY AND SAFETY OF FECAL MICROBIOTA TRANSPLANTATION FOR THE TREATMENT OF SEVERE AND SEVERE-COMPLICATED CLOSTRIDIOIDES DIFFICILE INFECTION: REPORT FROM A LARGE-VOLUME FMT CENTER	14
V.03.5: CHOLANGIOSCOPIC DIAGNOSIS OF AN INTRADUCTAL PAPILLARY BILIARY NEOPLASM: A RARE CAUSE OF BILIARY STRICTURE	14
T.04.7: ADHERENCE TO MEDITERRANEAN DIET AND DIET QUALITY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A SINGLE CENTER, OBSERVATIONAL CASE-CONTROL STUDY	14
Detection of coronary artery disease in liver transplant recipients: does stress echocardiography still have a role?	14

Efficacy and safety of cold snare polypectomy for sessile serrated polyps ≥ 10 mm: A systematic review and meta-analysis	14
BOC.02.8: DEFINING DIAGNOSTIC ULTRASONOGRAPHIC PARAMETERS IN ULCERATIVE COLITIS: A LONGITUDINAL PROSPECTIVE MULTICENTER STUDY	14
OC.02.5: METABOLIC DISORDERS IN COELIAC DISEASE AFTER GLUTENFREE DIET	14
OC.17.3: HOT VS COLD EMR: AWELL-KNOWN DUALISM IN A NORTHEASTERN ITALIAN EXPERIENCE	14
Author's Reply: “Immunomodulator combination versus mono therapy: Does combination therapy have an impact on infliximab therapy?”	14
Intractable diarrhea in infancy and molecular analysis: We are beyond the tip of the iceberg	14
Performance of different approaches to difficult biliary cannulation in endoscopic retrograde cholangiopancreatography: A systematic review and network meta-analysis	14
Author's reply: “Predictors for the development of diabetes mellitus following acute pancreatitis”	13
Immune dysregulation and porto-sinusoidal vascular disorder: A novel association with BENTA disease	13
Telemedicine in inflammatory bowel disease from its origin to the post pandemic golden age: A narrative review	13
Comparison of ciprofol–alfentanil and propofol–alfentanil sedation during bidirectional endoscopy: A prospective, double-blind, randomised, controlled trial	13
Current management of acute severe ulcerative colitis in Italy: Results from an IG-IBD survey	13
Integrating AI in medicine: Lessons from Chat-GPT's limitations in medical imaging	13
Bile detection of squamous cell carcinoma antigen (SCCA) in extrahepatic cholangiocarcinoma	13
Comment on “Impact of oral butyrate on clinical and biochemical parameters in IBD: A randomized placebo-controlled study targeting gut microbiota”	13
A new tool for rapid evaluation of endoscopic ultrasound through the needle biopsy in pancreatic cystic neoplasm	13
Rapidly progressive EBV-positive DLBCL arising from a duodenal diverticulum	13
Clinical Significance of histologic healing in IBD: Evidence from randomized controlled trials (RCT) and real world (RW) data	13
Angiopoietin 2 levels decrease after HCV-cure and reflect the evolution of portal hypertension	13
Prevalence of undiagnosed celiac disease in the adult general population of Italy in 1990: Baseline reference for testing current increasing incidence?	13
Giant polycystic liver disease presenting with rapid abdominal enlargement and jaundice	13
Aetiology-specific inflammation patterns in patients and rat models of compensated cirrhosis	13
Comparison of metabolic alterations, hepatic and cardiovascular damage between primary NAFLD and HIV-associated NAFLD: Role of low visceral adiposity	13
Where does capsule endoscopy fit in the diagnostic algorithm of small bowel intussusception?	13
The intratumoral balance of IgG4+ plasma cells and CD8+ T cells is associated with prognosis of intrahepatic cholangiocarcinoma after curative resection	12
Maintenance of clinical remission with biologics and small molecules in inflammatory bowel disease according to trial design: Meta-analysis	12
T.02.7 ANTHROPOMETRIC MEASUREMENTS, BODY COMPOSITION AND PREDICTIVE ROLE OF PHASE ANGLE IN WEIGHT LOSS AFTER BARIATRIC ENDOSCOPY: RESULTS FROM TWO SINGLE-CENTER, RANDOMIZED TRIALS	12
T.04.4 TOO MANY COUCH POTATOES AMONG MIDDLE-AGED INFLAMMATORY BOWEL DISEASE PATIENTS! FINDINGS FROM THE “BE-FIT-IBD-2” STUDY ON PATIENT-REPORTED PHYSICAL ACTIVITY LEVELS EXAMINING THEIR INTERACTIONS W	12
The 1st EoETALY Consensus on the Diagnosis and Management of Eosinophilic Esophagitis – Definition, Clinical Presentation and Diagnosis	12
Endoscopic ultrasound-guided drainage of pancreatic collections with dedicated metal stents: A nationwide, multicenter, propensity score-matched comparison	12
Lower rate of pancreatobiliary complications after sludge and microlithiasis pancreatitis compared to gallstone pancreatitis	12
Rectal cancer - French intergroup clinical practice guidelines for diagnosis, treatment, and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFP, RENAPE, SNFCP, AFEF, SFR, an	12
OC.01.6 MOLECULAR SIGNATURE OF ESOPHAGEAL STRICTURE AFTER CIRCUMFERENTIAL ENDOSCOPIC SUBMUCOSAL DISSECTION: PRELIMINARY INSIGHTS FROM A PILOT STUDY	12
Whether and when to biopsy coeliac patients: A never-ending story	12
Inflammation activity affects liver stiffness measurement by magnetic resonance elastography in MASLD	12
Comment on: Long-term effectiveness and safety of anti-TNF in pediatric-onset inflammatory bowel diseases: A population-based study	12
OC.14.4 EXPLORING MICROBIOTA-IMMUNE INTERACTIONS IN SHORT BOWEL SYNDROME AND CROHN’S DISEASE IN A MODEL OF HUMAN MICROBIOTA ASSOCIATED MICE	12
T.01.10 SELF-EXPANDING METAL STENT FOR REFRACTORY VARICEAL BLEEDING: AN UMBRELLA REVIEW WITH THE SYNTHESIS OF THE BEST EVIDENCE	12
Survival fragility in advanced hepatocellular carcinoma immunotherapy trials requires clinical context	12
TREM1 facilitates the development of gastric cancer through regulating neutrophil extracellular traps-mediated macrophage polarization	12
Impact of oral butyrate on clinical and biochemical parameters in IBD: A randomized placebo-controlled study targeting gut microbiota	12
PD-L1 and HER2 expression in gastric adenocarcinoma and their prognostic significance	12
Pancreatic steatosis is a strong risk factor for post-ERCP pancreatitis: An emerging concept	12
OC.02.20 SPLIT THE SPLIT: EFFICACY AND TOLERABILITY OF THE ASYMMETRIC SPLIT PREPARATION SCHEME WITH AVERY LOW VOLUME INTESTINAL PREPARATION: RANDOMIZED, SINGLEBLIND, PARALLEL-GROUP CLINICAL TRIAL	12
OC.14.5 THERAPEUTIC MODULATION OF GUT MICROBIOME TO TREAT IMMUNE-CHECKPOINT INHIBITORS-RELATED DIARRHEA AND COLITIS: EXPERIENCE OF A MICROBIOME CLINIC	12
Proton pump inhibitor dosing patterns are less than optimal among new referrals to an outpatient gastroenterology clinic	12
BOC.03.3 PERFORMANCE OF THREE ENDOSCOPIC GASTROPLASTY TECHNIQUES IN DIFFERENT OBESITY CLASSES. RESULTS AT 18 MONTHS FOLLOW-UP FROM A SINGLE CENTER, RANDOMIZED TRIAL	12
OC.07.9 RISK FACTORS AND INCIDENCE OF DYSPLASIA/ ESOPHAGEAL ADENOCARCINOMA IN PATIENTS WITH BARRETT’S ESOPHAGUS: DATA FROMA PROSPECTIVE, INTERNATIONAL, OBSVERVATIONAL STUDY - THE IOBER PROJECT	12
OC.19.3 CLINICAL RELEVANCE OF POSITIVE MOLECULAR STOOL TESTING FOR INTESTINAL PATHOGENS IN DIFFERENT GASTROINTESTINAL DISORDERS	12
Author's reply: “Toward safer rechallenge after severe immune-mediated hepatotoxicity: The need for dynamic and mechanism-informed risk stratification”	12
The role of miRNA in IBS pathogenesis, diagnosis and therapy: The latest thought	12
Cure after surgery for hepato-pancreato-biliary cancers: A systematic review	12
Cecal Trichuris trichiura infection discovered by colonoscopy	12
OC.15.2 ENDOSCOPIC TREATMENT OF PANCREATIC DUCT DISRUPTION AND CYSTIC DUCT LEAK USING CYANOACRYLATE: A CASE SERIES	12
Contrast-enhanced intraoperative ultrasound improved hepatic recurrence-free survival in initially unresectable colorectal cancer liver metastases	12
OC.13.6 POST-ERCP ACUTE PANCREATITIS IN LIVER TRANSPLANTED PATIENTS: A CASE-CONTROL STUDY	11
Liver steatosis assessed by CAP in patients with primary biliary cholangitis	11
Author's reply: Comment on “comparative efficacy of different bowel preparations for colonoscopy: A network meta-analysis"	11
To re-transplant, or not to re-transplant, that is the question	11
MSI-H locally recurrent rectal cancer: Immune checkpoint inhibitors vs. standard chemotherapy and pelvic exenteration	11
Colectomy rates in ulcerative colitis: A systematic review and meta-analysis	11
The Prognostic Nutritional Index in patients with microsatellite instability-high metastatic gastric or gastroesophageal cancers receiving immune checkpoint inhibitors	11
Evolving trends in liver cirrhosis: etiology, complications and comorbidities	11
Safety evaluation of extracorporeal shockwave lithotripsy for pancreatic stones: Experience based on a large chronic pancreatitis cohort	11
Comment on: “Measured glomerular filtration rate based on iohexol: Towards an application in liver transplantation.”	11
To be or NOD 2 be: The role of NOD2 in predisposing patients with cirrhosis towards infections	11
Gastric cancer screening in Western countries: A call to action	11
Net survival in colon and rectal cancer by stage according to neoadjuvant treatment. A French population-based study	11
Characterization of transcriptional and functional CD8 T cell heterogeneity to design individualized correction strategies for chronic HBV infection	11
A pragmatic strategy for the screening and treatment of portal hypertension in patients needing systemic treatment for advanced hepatocellular carcinoma	11
Early thoracentesis correlated with survival benefit in patients with spontaneous bacterial empyema	11
Factors affecting treatment decisions for endoscopically resected low- and high-risk malignant colorectal polyps in a screening setting	11
Delayed ERCP in the setting of severe acute cholangitis—How much delay is “Delayed”?	11
The current role of Tofacitinib in acute severe ulcerative colitis in adult patients: A systematic review	11
A journey from marginality to routine and beyond: single center experience with DCD utilization for liver transplantation in Italy	11
Obeticholic acid reduces lipid accumulation and fibrosis in a diet-induced ob/ob mouse model of NASH	10
Liver and spleen stiffness measure by transient elastograghy: a promising tool for the clinical management of patients after Fontan-type surgery circulation	10
Circulating interleukin-32 levels are associated with arterial hypertension in individuals at risk of NAFLD	10
Non-invasive assessment of hepatic steatosis by ultrasound-derived fat fraction (UDFF) in individuals at high-risk for metabolic dysfunction-associated steatotic liver disease	10
OC.06.9: ROLE OF UNKNOWN SIGNIFICANCE (VUS) AND NON-DISEASECAUSING (NDC) CFTR GENE MUTATIONS IN THE PATHOGENESIS OF ACUTE PANCREATITIS	10
OC.06.1: THE POSSIBILITY OF OBTAINING GOOD QUALITY AND QUANTITY RNA FROM EUS-FNA SAMPLES OF PANNENS: A PROSPECTIVE STUDY	10
Title Page	10
Liver function is a predictor of survival in patients with hepatocellular carcinoma in best supportive care	10
Exploring the interplay between sarcopenia, liver and cardiovascular damage in non-cirrhotic masld patients: a genetic perspective	10
T.06.6: CLINICAL AND GENETIC CHARACTERISTICS OF LYNCH SYNDROME: A RETROSPECTIVE STUDY IN A LARGE COHORT OF PATIENTS	10
PC.01.4 THE ROLE OF LARYNGOSCOPY IN GERD PATIENTS WITH ATYPICAL SYMPTOMS - A MULTICENTRE STUDY	10
Recurrence of primary sclerosing cholangitis after liver transplantation: A single center data	10
OC.11.4: LIVER TRANSPLANT IN ACLF AND ALD: AN EFFECTIVE OPTION WITH LIMITED ACCESS? PRELIMINARY RESULTS OF A SINGLE CENTER EXPERIENCE	10
OC.15.1: DIAGNOSTIC YIELD OF AI-ASSISTED CAPSULE ENDOSCOPY: AN INTERIM ANALYSIS OF COMPARISON BETWEEN EXPERTS AND TRAINEES	10
Antonio Ascione, 1941 - 2023: in memoriam	10
Skin injuries prevention during TIPS creation: use of “alert levels” and “trigger levels” in a high volume TIPS referral hospital (˃20 procedures/year)	10
Determinants of liver stiffness measurements changes in Metabolic dysfunction-Associated Steatotic Liver Disease: insights from two cohorts	10
OC.08.3 HCC RECURRENCE AFTER LIVER TRANSPLANTATION: THE VALIDATION OF RETREAT SCORE IN A SINGLE CENTER COHORT	10
Antisense oligonucleotides rescue an intronic splicing variant in the ABCB11 gene that causes progressive familial intrahepatic cholestasis type 2	10
OC.08.10: PROXIMAL ESOPHAGEAL IMPEDANCE BASELINE INCREASES THE YIELD OF IMPEDANCE-PH AND IS ASSOCIATED WITH RESPONSE TO PPIS IN CHRONIC COUGH PATIENTS	10